GOLDMAN SACHS GROUP INC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 157 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NEVRO CORP
ValueSharesWeighting
Q2 2024$2,590,104
-76.6%
307,613
-59.9%
0.00%
-100.0%
Q1 2024$11,083,688
-50.9%
767,568
-26.8%
0.00%
-50.0%
Q4 2023$22,553,528
+90.2%
1,048,026
+69.9%
0.00%
+33.3%
Q3 2023$11,856,633
+224.9%
616,890
+329.7%
0.00%
+200.0%
Q2 2023$3,648,974
-44.5%
143,547
-21.0%
0.00%
-50.0%
Q1 2023$6,569,661
-46.9%
181,733
-41.8%
0.00%
-33.3%
Q4 2022$12,366,026
+291964.9%
312,273
+243.7%
0.00%
+200.0%
Q3 2022$4,234
+12.9%
90,855
+6.2%
0.00%0.0%
Q2 2022$3,750
-99.9%
85,549
-9.2%
0.00%0.0%
Q1 2022$6,818,000
-9.3%
94,259
+1.6%
0.00%0.0%
Q4 2021$7,520,000
+88.8%
92,769
+171.1%
0.00%0.0%
Q3 2021$3,982,000
-78.8%
34,218
-69.8%
0.00%
-75.0%
Q2 2021$18,812,000
-61.2%
113,465
-67.3%
0.00%
-66.7%
Q1 2021$48,461,000
+2.7%
347,388
+27.4%
0.01%0.0%
Q4 2020$47,188,000
+9.6%
272,603
-11.8%
0.01%0.0%
Q3 2020$43,039,000
+16.2%
308,965
-0.3%
0.01%
+9.1%
Q2 2020$37,035,000
+97.5%
309,996
+65.3%
0.01%
+57.1%
Q1 2020$18,752,000
-39.0%
187,558
-28.2%
0.01%
-12.5%
Q4 2019$30,722,000
+50.3%
261,374
+10.0%
0.01%
+33.3%
Q3 2019$20,434,000
+370.9%
237,689
+255.1%
0.01%
+500.0%
Q2 2019$4,339,000
-47.9%
66,929
-49.8%
0.00%
-66.7%
Q1 2019$8,334,000
+186.4%
133,325
+78.2%
0.00%
+200.0%
Q4 2018$2,910,000
-42.1%
74,826
-15.1%
0.00%0.0%
Q3 2018$5,023,000
-91.6%
88,129
-88.2%
0.00%
-93.8%
Q2 2018$59,868,000
-24.4%
749,756
-18.0%
0.02%
-20.0%
Q1 2018$79,231,000
+19.0%
914,171
-5.2%
0.02%
+25.0%
Q4 2017$66,580,000
-39.2%
964,356
-19.9%
0.02%
-40.7%
Q3 2017$109,428,000
+27.9%
1,204,093
+4.8%
0.03%
+22.7%
Q2 2017$85,525,000
-38.6%
1,149,064
-22.7%
0.02%
-42.1%
Q1 2017$139,257,000
+35.7%
1,486,197
+5.2%
0.04%
+31.0%
Q4 2016$102,639,000
+23.4%
1,412,582
+77.2%
0.03%
+16.0%
Q3 2016$83,202,000
+535.2%
797,032
+348.8%
0.02%
+525.0%
Q2 2016$13,099,000
-63.1%
177,599
-71.9%
0.00%
-66.7%
Q1 2016$35,531,000
+149.4%
631,568
+199.2%
0.01%
+200.0%
Q4 2015$14,249,000
-5.4%
211,067
-35.0%
0.00%
-20.0%
Q3 2015$15,061,000
+236.5%
324,673
+289.9%
0.01%
+150.0%
Q2 2015$4,476,000
+1119.6%
83,270
+776.4%
0.00%
Q4 2014$367,0009,5010.00%
Other shareholders
NEVRO CORP shareholders Q2 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$45,155,2751.48%
ARMISTICE CAPITAL, LLC 2,356,000$59,889,5200.87%
Rock Springs Capital Management LP 1,211,400$30,793,7880.73%
ArrowMark Colorado Holdings LLC 1,817,189$46,192,9440.51%
Palo Alto Investors LP 186,259$4,734,7040.38%
K2 PRINCIPAL FUND, L.P. 51,000$1,296,4200.30%
TD Capital Management LLC 84,648$2,151,7520.26%
Point72 Europe (London) LLP 73,800$1,875,9960.25%
Venator Management LLC 25,000$6360.23%
Virtus Investment Advisers, Inc. 12,500$317,7500.22%
View complete list of NEVRO CORP shareholders